| 摘要 |
A method is provided for inhibiting the gamma to beta -globin switching in subjects afflicted with beta -globin disorders. The method is particularly adapted for ameliorating the clinical symptoms of sickle cell anemia by periodically introducing butyrate, or certain isomers, homologs, analogs or chemical variations thereof, into the bloodstream of the subject prior to natural completion of the switching process.
|
